Macrophage-mediated inflammation plays essential roles
in multiple-organ
injury. Sinensetin (SNS) at least exhibits anti-inflammation, antioxidant,
and antitumor properties. However, the underlying mechanism of SNS-targeted
macrophage-mediated inflammation remains elusive. In the present study,
our results showed that SNS suppressed lipopolysaccharide (LPS)-induced
inflammation to ameliorate lung and liver injuries. Mechanistically,
SNS significantly inhibited M1-type macrophage polarization and its
NLRP3 inflammasome formation to significantly decrease tumor necrosis
factor α (TNFα) and IL-6 expression, while increasing
IL-10 expression. Moreover, SNS interacted and activated SIRT1 to
promote NRF2 and its target gene SOD2 transcription, which subsequently
decreased LPS-induced inflammation. SIRT1 knockdown impaired the effects
of SNS on the inhibition of macrophage polarization, NLRP3 inflammasome
formation, and NRF2/SOD2 signaling. Taken together, our results showed
that SNS is a potential and promising natural active ingredient to
ameliorate inflammatory injury via activating SIRT1/NRF2/SOD2
signaling.